BioMed Research International

Cytokines in Systemic Lupus Erythematosus


Publishing date
15 Sep 2010
Status
Published
Submission deadline
15 Jan 2010

1Brigham Young University, Provo, UT 84601, USA

2Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA

3Pathology Department, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA


Cytokines in Systemic Lupus Erythematosus

Description

Systemic lupus erythematosus (SLE) is a disease of a dysregulated immune system. As some of the principal modifiers of immune responses, cytokines figure prominently into the etiology and pathogenesis of SLE. Cytokines can be products of both the innate and the adaptive immune systems and affect the majority of the cell types involved in lupus. Recent work using microarray techniques and genetic analysis has strengthened the association between cytokine dysregulation and SLE. Furthermore, cytokines represent a relatively easy target for therapeutic intervention via blockade with biological agents, such as the recently announced encouraging trials of inhibitors to Blys. A thorough understanding of the role these important immune control molecules play in SLE is crucial to understanding the disease and how to ameliorate its effects.

We invite authors to present original research articles as well as review articles that will stimulate work in the evolving area of cytokine biology in SLE. We are particularly interested in papers that address the role of cytokines in the etiology of SLE, or targeting of cytokines as part of an SLE therapeutic strategy. Topics that will be emphasized include, but are not limited to:

  • Genetic associations with cytokine profile in SLE
  • Identification of cytokine dysregulation in SLE
  • Use of cytokines as SLE biomarkers
  • Animal studies that identify the importance of cytokines or groups of cytokines in an SLE model
  • The role of IL-6, IL-10, IL-17, BLyS, interferons, or TNF-family members in SLE
  • Influence of SLE-associated cytokines upon cellular immunity and/or humoral autoimmunity
  • Clinical associations with cytokine patterns in SLE
  • Therapeutic strategies for SLE involving cytokines

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jbb/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.